Cargando…
Impact of Improper Storage of ChAdOx1-S (AstraZeneca) Vaccine on Its Efficacy and Safety
Background: In May 2021, there was an incident regarding giving patients AstraZeneca vaccines stored improperly. They were stored at room temperature (21 degrees centigrade) for 18 h, 12 h longer than the producer recommends. Aim of the study: The paper aims to contribute to the body of knowledge co...
Autores principales: | Mikołajczyk, Marek, Lewandowski, Roman A., Goncharuk, Anatoliy G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865338/ https://www.ncbi.nlm.nih.gov/pubmed/36679938 http://dx.doi.org/10.3390/vaccines11010093 |
Ejemplares similares
-
Psoriatic flare following Oxford-AstraZeneca ChAdOx1 COVID-19 and influenza vaccines
por: Teh, Natalie, et al.
Publicado: (2021) -
Acute Arterial Occlusion Following ChAdOx1 nCov-19 (Oxford–AstraZeneca) Vaccination
por: Ali, Azhar, et al.
Publicado: (2022) -
AstraZeneca ChAdOx1-S COVID-19 vaccine can be safely administered in patients with EDTA allergy
por: Ali, Syed B., et al.
Publicado: (2022) -
Stevens-Johnson Syndrome Following ChAdOx1 nCoV-19 Vaccination (AstraZeneca)
por: Lee, Hyo Jin, et al.
Publicado: (2023) -
Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford–AstraZeneca) vaccination
por: Robichaud, Julie, et al.
Publicado: (2021)